Home › Trial NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Trial IDNCT07226843
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorEli Lilly and Company
- Enrollment460
- Start date2026-04-17
- ConditionsLymphoma, Non-Hodgkin's · Lymphoma, Diffuse Large B-Cell · Follicular Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.